| 标题 |
FOLFOXIRI/bevacizumab versus doublets/bevacizumab as initial therapy of unresectable liver-only, right-sided and/or RAS or BRAF mutated metastatic colorectal cancer: An individual patient data-based pooled analysis of randomized trials |
| 网址 | |
| DOI | |
| 其它 |
期刊:European Journal of Cancer 作者:Carlotta Antoniotti; Federica Marmorino; Daniele Rossini; Hans‐Joachim Schmoll; Sara Lonardi; et al 出版日期:2025-08-18 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)